. 2013 Oct 28;104(12):1711–1717. doi: 10.1111/cas.12292

Table 2.

Incidence of carcinoma and quantitative evaluation of neoplastic lesions in ventral and lateral prostate

Treatment	Number of rats	Ventral				Lateral
		Incidence of carcinoma	% of lesions in prostate			Incidence of carcinoma	% of lesions in prostate
		Incidence of carcinoma	LG‐PIN	HG‐PIN	Carcinoma	Incidence of carcinoma	LG‐PIN	HG‐PIN	Carcinoma
Control	11	11 (100%)	6.6 ± 2.5	81.8 ± 4.8	11.7 ± 4.5	10 (91%)	11.8 ± 5.2	82.8 ± 6.8	5.4 ± 3.9
100 mg/L	11	11 (100%)	8.0 ± 2.5	83.6 ± 3.8	8.4 ± 2.8^*	10 (91%)	17.4 ± 4.3	80.1 ± 4.3	2.5 ± 1.4^*
500 mg/L	11	11 (100%)	8.3 ± 1.6	87.3 ± 3.2^**	4.4 ± 1.9***	6 (55%)	26.8 ± 9.9***	71.8 ± 9.0^**	1.5 ± 1.7^**

*,**,***Indicate significant difference from the control group, P < 0.05, 0.1, 0.001, respectively.